INSIGHTS ON DRUG DEVELOPMENT
-
![TA Antibody Bucket Image]( "Why DSC Testing Is A Critical Step In Developing Biosimilar Drugs")
Why DSC Testing Is A Critical Step In Developing Biosimilar DrugsExplore the importance of testing in the regulatory process and how tools like Differential Scanning Calorimetry (DSC) are helping to bring more biosimilars to patients in need.
-
![Virtual Pharma Expo]( "KORSCH Virtual Pharma Expo September 2025: Oral Solid Dose Manufacturing And Packaging")
KORSCH Virtual Pharma Expo September 2025: Oral Solid Dose Manufacturing And PackagingSimulate high-speed tablet production early in development with minimal material. Gain accurate scale-up, faster material characterization, and flexible formulation options—all with one compaction simulator.
-
![GettyImages-2190246741 lab]( "How To Capture Growth In The Expanding Metabolic Drug Market")
How To Capture Growth In The Expanding Metabolic Drug MarketDriven by GLP-1 success and rising obesity rates, R&D investment in metabolic disease therapies now rivals oncology, demanding rapid development to overcome market challenges.
-
![GettyImages-2036497698 clinical lab]( "Target Product Profiles And Phase 1 Clinical Plans: Laying The Groundwork For Success")
Target Product Profiles And Phase 1 Clinical Plans: Laying The Groundwork For SuccessBy integrating scientific rigor, regulatory foresight, and market awareness into early-stage planning, companies can leverage a robust TPP to optimize decision-making and development.
-
Evolving Gene Editing For Rare Disease Drug Development10/9/2025
Explore how scalable gene editing platforms are advancing therapies for ultra-orphan conditions, with insights into manufacturing models, regulatory strategies, and clinical approaches.
-
Navigating The Analytical Complexity Of Oligonucleotide Therapeutics9/13/2024
From identity and purity testing using chromatography and electrophoresis to PCR and microbial studies, explore advanced analytical solutions tailored for siRNA, miRNA, pDNA, and mRNA products.
-
Improving The Efficiency And Quality Of Advanced Imaging And Analysis8/27/2025
Human-relevant models are transforming drug screening. Find out how overcoming 3D cell culture challenges with integrated innovations accelerates discovery and brings effective treatments to patients faster.
-
Rheological Properties Of Pharmaceutical Excipients: Lactose Monohydrate And Carboxymethyl Cellulose12/30/2024
Explore lactose monohydrate and CMC rheology, highlighting their flow, cohesion, and compressibility properties to optimize pharmaceutical formulations under varying stress and temperature conditions.
-
The Analytical Advantage Across The Development Lifecycle5/7/2026
Integrated, regulatory‑ready analytics help accelerate development, strengthen submissions, and ensure consistent product quality throughout the pharmaceutical lifecycle.
DRUG DEVELOPMENT SOLUTIONS
-
![Structure Elucidator Suite™]( "Elucidate Complex Structures From Real Data")
Characterize the Best-Fit Structure for Your NMR and MS Data
ACD/Structure Elucidator Suite is the industry-leading software solution for computer-assisted structure elucidation (CASE). It offers a reliable workflow and accurate results for de novo elucidation of complex organic compound structures.
Use Structure Elucidator Suite to:
- Determine structures using NMR and other analytical data
- Generate all the candidate structures that fit your NMR and MS data
- Rank the generated structures and identify the most probable one
- Determine 3D configuration from a 2D structure using NOESY/ROESY data
- Dereplicate previously identified compounds
- Search fragment databases or manually define fragments for partially known structures
- Report the final structure and add SDFiles to the prediction databases
-
![Flow Cytometry Solutions]( "Flow Cytometry Solutions")
Flow cytometry is a powerful and versatile technique to analyze the physical and chemical characteristics of cells or particles.
-
![Millipore Express®]( "Millipore Express® Family Guide")
Examine how sterilizing-grade filters with high flux and broad compatibility support efficient bioprocessing across mAbs, vaccines, and viral vectors.
-
![paylinker-cdmo-GettyImages-1287846309]( "Payload-Linker")
Learn how high‑potency infrastructure, strong impurity control, and scalable payload‑linker capabilities help teams manage risk, maintain purity, and advance toward clinical‑stage ADC development.
-
![Chip-S1]( "Complete Organ-Chip Solutions To Fast-Track Your Drug Discovery")
From cancer models to high-throughput screening, Organ-Chip platforms accelerate development, improve safety, and support regulatory compliance for next-generation therapies.
